End-to-End Programme
Idea through to commercialisation, run as one process by one team: discovery, validation, formulation and scale-up, so evidence generated in one stage feeds directly into the next instead of being reinterpreted by a different supplier.
Book a free R&D diagnostic See how the stages connectWhy run it as one programme
Brands often buy discovery, testing and formulation from three different suppliers, each of whom reinterprets what the last one found. That is where a project quoted at three years quietly becomes eighteen months of rework before it becomes eighteen months of progress.
An End-to-End Programme keeps the same team and the same thread of evidence from the first screening result to the finished manufacturing specification. Bring an idea, an unproven ingredient, or a validated active that still needs a route to market. Every stage is also available on its own: Discovery Sprint, Validation Programme, and Formulation Programme. The End-to-End Programme is what happens when a brand books all three under one scope instead of three.
How the four stages connect
A 30 minute session establishes which kind of problem you actually have and which stages the programme needs to include.
AI guided screening identifies and prioritises candidate ingredients or actives, with the scientific rationale behind each one.
The lead candidate is tested in laboratory assays, generating evidence that stands up to claims, retailer or regulatory scrutiny.
The validated active is built into a stable formulation, optimised, and taken through to a manufacturing specification with our production partners.
What you get from an End-to-End Programme
This is the full pipeline as one scoped, priced engagement, not four separate purchases negotiated four separate times.
Deliverables
- A validated lead ingredient or active, with the evidence behind the choice
- A technical evidence report suitable for claims, retailer or regulatory review
- A prototype formulation, optimised and stability tested
- A manufacturing specification ready to hand to a production partner
- Novel intellectual property you can file on, where the work supports it
Good to know
- Typical timeline: 3 to 9+ months, depending on how much of the pipeline is needed
- Indie and emerging brands: idea through to a launch-ready product
- Enterprise and global brands: multi-stage, strategic R&D programmes
- Investment is scoped at the R&D Diagnostic, which is free and comes first
Bring the whole problem, not just the next step
Two brands who ran this route end to end: Layla & Kays and Couronne, both now in market.
Not sure how much of the pipeline you need? That is exactly what the diagnostic is for. You can also read our case studies or meet the scientific team.